嵌入式循環記錄器的全球市場

到 2030 年，全球植入式循環記錄器市場規模將達到 26 億美元

全球嵌入式循環記錄器市場規模預計在2024年為15億美元，到2030年將達到26億美元，2024年至2030年的複合年成長率為9.0%。手動嵌入式循環記錄器是本報告分析的細分市場之一，預計其複合年成長率為10.3%，到分析期結束時市場規模將達到17億美元。自動嵌入式循環記錄器細分市場在分析期間的複合年成長率預計為6.9%。

美國市場規模估計為 4.173 億美元，中國市場預計複合年成長率為 14.2%

美國植入式循環記錄器市場規模預計在2024年達到4.173億美元。預計到2030年，作為世界第二大經濟體的中國市場規模將達到5.72億美元，在2024-2030年的分析期內，複合年成長率為14.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.5%和8.7%。在歐洲，預計德國市場的複合年成長率約為6.1%。

全球嵌入式循環記錄器市場-主要趨勢與促進因素摘要

哪些因素推動了植入式循環記錄器在現代心臟病學中的臨床相關性？

植入式循環記錄器 (ILR)，又稱為可插入式心臟監視器 (ICM)，徹底革新了長期心律監測，能夠實現長達三年的持續心電圖監測。這些皮下裝置尤其適用於診斷間歇性心律不整，例如隱源性暈厥、隱源性中風和陣發性心房顫動。與傳統的心電圖監測和體外事件記錄儀不同，ILR 消除了短期資料收集的限制以及患者對穿戴式電極的違規。即使是無症狀患者，不間斷的心臟監測也能顯著提高診斷率，尤其是在心律不整發作罕見或難以預測的情況下。

美國心臟病學會 (AHA) 和歐洲心臟病學會 (ESC) 的臨床指南擴大推薦 ILR 作為不明原因暈厥或短暫性意識喪失患者的一線治療方案，進一步證明了其在心臟診斷領域的地位。 ILR 的應用範圍不僅限於暈厥，也擴大用於評估中風後不明原因事件，而未檢測到的心房顫動可能是這些事件的潛在誘因。這些設備在長期監測遺傳性心律不整症候群患者以及心房顫動消融術後復發性心房顫動方面也顯示出巨大的價值，從而擴大了其在普通心臟病學和電生理學亞專科中的效用。

技術進步如何改變嵌入式循環記錄器的格局？

近年來，ILR 設計和資料處理能力不斷創新。新一代設備體積越來越小，方便進行微創門診植入手術。例如，現在的設備體積小於一立方厘米，植入時間不到五分鐘。這些更小巧的外形規格不僅提高了患者的舒適度，還降低了手術風險和醫療保健系統的成本。電池壽命也顯著提升，大多數設備現在無需更換即可使用 3-4 年。

在數位化方面，遠端遠端檢測系統與智慧型手機患者應用程式的整合顯著改善了即時數據存取和臨床工作流程。醫生現在可以收到心臟收縮、心搏過緩心房顫動等關鍵事件的即時警報，以便更早介入。同時，人工智慧和機器學習演算法正在被嵌入到雲端基礎平台中，以減少誤報並自動識別大型資料集中的模式。這些功能在遠端患者監護計畫、遠距心臟病學服務以及傳統臨床環境以外的慢性病族群管理中尤其有益。

採用熱點和擴大臨床應用有哪些？

目前，北美和歐洲憑藉著完善的報銷政策、強大的臨床基礎設施以及遠端監控技術的早期整合，在全球 ILR 的採用率方面處於領先地位。然而，由於心臟診斷服務的普及、對心房顫動相關中風的認知提高以及公共對心臟健康的投入增加，亞太和拉丁美洲等新興市場的植入數量正在增加。各國政府和保險公司也開始意識到 ILR 在降低復發性住院和中風相關殘疾方面的成本效益。

在臨床應用方面，雖然暈厥診斷仍是主要指徵，但 ILR 在中風二級預防計畫的普及度正在迅速提升。許多卒中中心正在將 ILR 納入其診斷方案中，以檢測隱源性陣發性心房顫動，這是一種常見但未被充分診斷​​的栓塞性中風原因。此外，ILR 在電生理研究中的消融後監測以及結構性心臟病的管理中的作用正在不斷擴大，尤其是在植入心臟心律調節器或心臟導管室 (CRT) 等心臟裝置的患者中，它能夠提供輔助診斷依據。兒科心臟病學是另一個前沿領域，ILR 在評估年輕族群遺傳性心律不整方面正日益受到關注，儘管出於解剖和操作方面的考慮，需要謹慎的選擇標準。

嵌入式循環記錄器市場的成長受到多種因素的推動。

首先，設備小型化和微創插入技術的不斷創新顯著降低了高所得和中等收入國家的採用門檻。這為其在門診和以地區為基礎心臟護理模式中的應用開闢了新的途徑。其次，遠端監控技術與雲端基礎分析平台的整合使ILR成為一種互聯醫療工具，這與全球向數位化醫療、分散式醫療和遠端監控的轉變相契合。這些進步使循環系統能夠有效率地管理更大的患者群體，同時保持診斷的準確性。

第三，不斷擴大的臨床使用案例，特別是中風診斷、心房顫動監測、心房顫動消融後監測、遺傳性心律不整檢測等，正在增加可尋址患者群體。此外，美國、德國和日本等主要市場的支持性報銷政策對於推動醫生採用和患者可及性至關重要。第四，全球心血管疾病（主要是心房顫動和中風）的增加，推動了對早期和可靠心律診斷的需求，從而產生了對 ILR 的持續需求。最後，由於人們認知的提高、心臟病學基礎設施的改善以及主要設備製造商的有針對性的銷售策略，這些設備在新興地區的供應增加也推動了市場的成長。

部分

產品（手動產品、自動產品）、適應症（心血管暈厥適應症、中風適應症、心臟衰竭適應症、心律不整適應症、心房顫動適應症、束支傳導阻滯適應症、其他適應症）、最終用戶（醫院最終用戶、心臟中心和診所最終用戶、門診手術中心最終用戶）

受訪公司範例（總合34家）

• Abbott Laboratories
• Angel Medical Systems, Inc.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Insight, Inc.
• Cardiovascular Systems, Inc.
• ConMed Corporation
• Cook Medical
• GE Healthcare
• HeartWare International, Inc.
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips NV
• LifeWatch Technologies
• Medtronic plc
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Philips Healthcare
• Preventice Solutions
• ProgenyHealth

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口（成品和原始OEM）來預測其競爭地位的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括人為提高銷貨成本、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

全球產業分析師密切關注來自全球頂尖首席經濟學家（14,949位）、智庫（62家）以及貿易和產業協會（171家）的專家的意見，以評估其對生態系統的影響並應對新的市場現實。我們追蹤了來自每個主要國家的專家和經濟學家對關稅及其對本國影響的看法。

全球產業分析師預計，這場動盪將在未來2-3個月內逐漸平息，新的世界秩序將更加清晰地建立。全球產業分析師正在即時追蹤這些事態發展。

2025年4月：談判階段

在4月的報告中，我們將探討關稅對全球整體市場的影響，並提供區域市場調整。我們的預測是基於歷史數據和不斷變化的市場影響因素。

2025年7月：最終關稅調整

在各國宣布最終重置後，客戶將在 7 月收到免費更新，最終更新將包含明確的關稅影響分析。

相互和雙邊貿易及關稅影響分析：

美國<>中國<>墨西哥<>加拿大<>歐盟<>日本<>印度<>其他176個國家

領先的產業經濟學家：全球產業分析師知識庫追蹤了 14,949 位經濟學家，其中包括來自民族國家、智庫、貿易和產業協會、大型企業以及各領域專家的最具影響力的首席經濟學家，他們共用了這場前所未有的全球經濟狀況模式轉移的影響。我們超過 16,491 份報告大多遵循基於里程碑的兩階段發布計劃。

目錄

第1章調查方法

第2章執行摘要

• 市場概覽
• 主要企業
• 市場趨勢和促進因素
• 全球市場展望

第3章市場分析

• 美國
• 加拿大
• 日本
• 中國
• 歐洲
• 法國
• 德國
• 義大利
• 英國
• 西班牙
• 俄羅斯
• 其他歐洲國家
• 亞太地區
• 澳洲
• 印度
• 韓國
• 其他亞太地區
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中東
• 伊朗
• 以色列
• 沙烏地阿拉伯
• 阿拉伯聯合大公國
• 其他中東地區
• 非洲

第4章 競賽

Global Implantable Loop Recorders Market to Reach US$2.6 Billion by 2030

The global market for Implantable Loop Recorders estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 9.0% over the analysis period 2024-2030. Manual Implantable Loop Recorders, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.7 Billion by the end of the analysis period. Growth in the Automatic Implantable Loop Recorders segment is estimated at 6.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$417.3 Million While China is Forecast to Grow at 14.2% CAGR

The Implantable Loop Recorders market in the U.S. is estimated at US$417.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$572.0 Million by the year 2030 trailing a CAGR of 14.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.5% and 8.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 6.1% CAGR.

Global Implantable Loop Recorders Market - Key Trends & Drivers Summarized

What Is Driving the Clinical Relevance of Implantable Loop Recorders in Modern Cardiology?

Implantable loop recorders (ILRs), also known as insertable cardiac monitors (ICMs), have revolutionized long-term cardiac rhythm monitoring by enabling continuous ECG surveillance for up to three years. These subcutaneous devices are particularly valuable in diagnosing unexplained syncope, cryptogenic stroke, and intermittent arrhythmias, such as paroxysmal atrial fibrillation. Unlike traditional Holter monitors or external event recorders, ILRs eliminate the limitations of short-term data capture and patient non-compliance with wearable electrodes. This ability to provide uninterrupted cardiac monitoring, even in asymptomatic patients, significantly enhances diagnostic yield, especially in cases where arrhythmic episodes are infrequent or unpredictable.

Clinical guidelines from the American Heart Association (AHA) and European Society of Cardiology (ESC) increasingly recommend ILRs as first-line tools in patients with unexplained syncope or transient loss of consciousness, further legitimizing their place in cardiac diagnostic pathways. Beyond syncope, there is growing utilization of ILRs in post-stroke evaluation for cryptogenic causes, where undetected atrial fibrillation may be an underlying factor. These devices are also proving critical in long-term monitoring for patients with inherited arrhythmia syndromes or post-ablation monitoring for recurrence of atrial fibrillation, expanding their utility in both general cardiology and electrophysiology subspecialties.

How Are Technology Advancements Reshaping the Implantable Loop Recorder Landscape?

The past few years have witnessed rapid innovation in ILR design and data handling capabilities. New-generation devices are increasingly miniaturized, facilitating minimally invasive insertion procedures that can be performed in outpatient settings. For instance, some devices now measure less than 1 cubic centimeter in volume and can be implanted in under five minutes. These miniaturized form factors not only improve patient comfort but also reduce procedural risk and cost burden on healthcare systems. Battery longevity has also improved significantly, with most devices now lasting between three and four years without replacement.

On the digital front, integration with remote telemetry systems and smartphone-compatible patient apps has dramatically improved real-time data access and clinical workflow. Physicians can now receive instant alerts for critical events such as asystole, bradycardia, or atrial fibrillation episodes, enabling earlier interventions. In parallel, artificial intelligence and machine learning algorithms are being embedded into cloud-based platforms to reduce false positives and automate pattern recognition across large datasets. These capabilities are especially beneficial in remote patient monitoring programs, telecardiology services, and in managing chronic disease populations outside traditional clinical settings.

Where Are the Adoption Hotspots and Which Clinical Applications Are Expanding?

North America and Europe currently lead global ILR adoption, driven by well-established reimbursement policies, strong clinical infrastructure, and early integration of remote monitoring technologies. However, emerging markets in Asia-Pacific and Latin America are witnessing a rise in implant volumes due to improved access to cardiac diagnostics, rising awareness of atrial fibrillation-related stroke, and increased investment in public cardiac health initiatives. Governments and insurers are also starting to recognize the cost-effectiveness of ILRs in reducing recurrent hospitalizations and stroke-related disability.

In terms of clinical use, while syncope diagnosis remains the leading indication, ILRs are seeing rapid uptake in secondary stroke prevention programs. Many stroke centers are incorporating ILRs into their diagnostic workup to detect occult paroxysmal atrial fibrillation-a common but underdiagnosed cause of embolic strokes. Furthermore, their role is expanding in electrophysiology for post-ablation surveillance and in structural heart disease management, particularly among patients with implanted cardiac devices like pacemakers or CRTs, where ILRs provide adjunctive diagnostic insights. Pediatric cardiology is another frontier, where ILRs are gaining interest for evaluating inherited rhythm disorders in younger populations, albeit with careful selection criteria due to anatomical and procedural considerations.

The Growth in the Implantable Loop Recorders Market Is Driven by Several Factors…

First, continuous innovation in device miniaturization and minimally invasive insertion techniques has significantly lowered the threshold for adoption across both high- and middle-income countries. This has opened new avenues for use in ambulatory and community-based cardiac care models. Second, the integration of remote monitoring technologies and cloud-based analytics platforms has turned ILRs into connected health tools, aligning well with the global shift toward digital health, decentralized care, and telemonitoring. These advancements allow cardiologists to efficiently manage larger patient cohorts while maintaining diagnostic precision.

Third, the expanding clinical use cases-particularly in cryptogenic stroke diagnostics, atrial fibrillation surveillance, post-ablation monitoring, and inherited rhythm disorder detection-are collectively enlarging the addressable patient pool. Additionally, supportive reimbursement policies in key markets such as the U.S., Germany, and Japan have been critical in driving both physician adoption and patient access. Fourth, rising global cardiovascular disease prevalence, especially atrial fibrillation and stroke, is fueling the need for early and reliable rhythm diagnostics, creating sustained demand for ILRs. Finally, market growth is also bolstered by the increasing availability of these devices in emerging regions, thanks to growing awareness, improving cardiology infrastructure, and targeted distribution strategies by leading device manufacturers.

SCOPE OF STUDY:

The report analyzes the Implantable Loop Recorders market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Manual Product, Automatic Product); Indication (Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication, Other Indications); End-User (Hospitals End-User, Cardiac Centers & Clinics End-User, Ambulatory Surgery Centers End-User)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

• Abbott Laboratories
• Angel Medical Systems, Inc.
• Biotronik SE & Co. KG
• Boston Scientific Corporation
• Cardiac Insight, Inc.
• Cardiovascular Systems, Inc.
• ConMed Corporation
• Cook Medical
• GE Healthcare
• HeartWare International, Inc.
• Hill-Rom Holdings, Inc.
• iRhythm Technologies, Inc.
• Koninklijke Philips N.V.
• LifeWatch Technologies
• Medtronic plc
• MicroPort Scientific Corporation
• Nihon Kohden Corporation
• Philips Healthcare
• Preventice Solutions
• ProgenyHealth

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Implantable Loop Recorders - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Atrial Fibrillation and Unexplained Syncope Spurs Demand for Continuous Cardiac Monitoring
  • Growing Emphasis on Early Diagnosis of Cardiac Arrhythmias Propels Adoption of Implantable Loop Recorders
  • Increasing Geriatric Population Base Strengthens Business Case for Long-Term Cardiac Monitoring Solutions
  • Technological Advancements in Miniaturization and Battery Life Extend Device Usability and Drive Market Expansion
  • Integration of Remote Monitoring Capabilities Enhances Care Continuity and Accelerates Demand for Smart ILRs
  • Rising Use of AI and Predictive Analytics in Cardiac Monitoring Expands the Value Proposition of ILR Devices
  • Expansion of Outpatient Cardiac Monitoring Programs Throws the Spotlight on Cost-Effective ILR Solutions
  • Increasing Cardiac Monitoring Adoption Across Emerging Economies Expands Global Addressable Market Opportunity
  • Shift Toward Minimally Invasive and Ambulatory Monitoring Procedures Drives Preference for ILRs Over Holter Monitors
  • Growing Investments in Cardiac Telehealth Infrastructure Sustain Growth Momentum in Remote ILR Services
  • Rising Clinical Use of ILRs in Unexplained Strokes Expands Indications and Supports Market Growth
  • Growing Role of Digital Health Ecosystems Facilitates Seamless Data Integration and Boosts Adoption Rates
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Implantable Loop Recorders Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Implantable Loop Recorders by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Manual Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Manual Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Automatic Product by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Automatic Product by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Hospitals End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Hospitals End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Cardiac Centers & Clinics End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Cardiac Centers & Clinics End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Ambulatory Surgery Centers End-User by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Ambulatory Surgery Centers End-User by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Cardiovascular Syncope Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Cardiovascular Syncope Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Stroke Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Stroke Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Heart Failure Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Heart Failure Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Cardiac Arrhythmia Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Cardiac Arrhythmia Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Atrial Fibrillation Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Atrial Fibrillation Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Bundle Branch Block Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Bundle Branch Block Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 41: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• JAPAN
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• CHINA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 68: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: China Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: China 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 71: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• EUROPE
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 77: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 78: Europe Historic Review for Implantable Loop Recorders by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: Europe 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 80: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• FRANCE
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 89: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: France Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: France 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 92: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: France Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: France 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 95: France Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• GERMANY
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 98: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: Germany Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: Germany 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 101: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Germany Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: Germany 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 107: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Italy Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Italy 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 110: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Italy Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Italy 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 116: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: UK Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: UK 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 119: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: UK Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: UK 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 122: UK Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 125: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Spain Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: Spain 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 128: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Spain Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: Spain 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 134: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Russia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Russia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 137: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Russia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Russia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Rest of Europe Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Europe Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 153: Asia-Pacific Historic Review for Implantable Loop Recorders by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 164: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Australia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Australia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 167: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Australia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Australia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• INDIA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 173: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: India Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: India 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 176: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: India Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: India 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 179: India Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 182: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: South Korea Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: South Korea 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 185: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: South Korea Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: South Korea 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 200: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 201: Latin America Historic Review for Implantable Loop Recorders by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Latin America 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 203: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 212: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Argentina Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Argentina 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 215: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Argentina Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Argentina 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 221: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Brazil Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Brazil 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 224: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Brazil Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Brazil 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 230: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Mexico Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Mexico 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 233: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Mexico Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Mexico 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Latin America Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Latin America Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 248: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 249: Middle East Historic Review for Implantable Loop Recorders by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Middle East 15-Year Perspective for Implantable Loop Recorders by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 251: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 260: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Iran Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Iran 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 263: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Iran Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Iran 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 269: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Israel Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Israel 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 272: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Israel Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Israel 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Saudi Arabia Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Saudi Arabia Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 287: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: UAE Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: UAE 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 290: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: UAE Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: UAE 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Middle East Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Middle East Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030
• AFRICA
  • Implantable Loop Recorders Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 305: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Product - Manual Product and Automatic Product - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Africa Historic Review for Implantable Loop Recorders by Product - Manual Product and Automatic Product Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Africa 15-Year Perspective for Implantable Loop Recorders by Product - Percentage Breakdown of Value Sales for Manual Product and Automatic Product for the Years 2015, 2025 & 2030
  • TABLE 308: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Africa Historic Review for Implantable Loop Recorders by End-user - Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Africa 15-Year Perspective for Implantable Loop Recorders by End-user - Percentage Breakdown of Value Sales for Hospitals End-User, Cardiac Centers & Clinics End-User and Ambulatory Surgery Centers End-User for the Years 2015, 2025 & 2030
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Implantable Loop Recorders by Indication - Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Implantable Loop Recorders by Indication - Percentage Breakdown of Value Sales for Cardiovascular Syncope Indication, Stroke Indication, Heart Failure Indication, Cardiac Arrhythmia Indication, Atrial Fibrillation Indication, Bundle Branch Block Indication and Other Indications for the Years 2015, 2025 & 2030

IV. COMPETITION